Dear All, The IDWeek 2024 program committee is again seeking programs on novel antimicrobial agents and novel diagnostics for presentation in pipeline sessions! Here’s what is sought: “Industry partners are invited to submit antimicrobials that are in preclinical stages of development (Phase II and III preferred) or recently approved after January 2024. “The pipeline sessions will include antibacterials, antifungals, and antivirals (excluding COVID-19 and HIV). “The